Healthcare Services

Chronic Pain Market Growth Driven by Increasing Patient Population

April 20, 2026April 20, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Changes In Market Value Are Expected For The Chronic Pain Market Over The 2026–2030 Period?

The chronic pain market has demonstrated strong growth in recent years. This market is expected to expand from $84.66 billion in 2025 to $91.67 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.3%. The expansion observed historically is attributable to factors like the rising prevalence of chronic diseases, an increase in neuropathic and musculoskeletal pain incidence, broader access to pain medications, heightened clinical awareness of chronic pain, and the proliferation of pain clinics.

The chronic pain market is projected to experience substantial expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $127.4 billion, advancing at a compound annual growth rate (CAGR) of 8.6%. This expansion during the projected timeframe is largely driven by factors such as the escalating demand for tailored pain treatments, the increasing integration of bioelectronic devices, the broader availability of telehealth services for pain management, a heightened emphasis on alternatives to opioids, and greater financial commitment to pain research. Key developments expected during this period encompass the wider implementation of holistic pain care approaches, the expanding application of neuromodulation devices, a notable shift towards non-opioid pharmaceutical options, the proliferation of pain management solutions accessible from home, and improved embedding of digital health technologies.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Which Key Drivers Are Affecting The Chronic Pain Market Development?

The expansion of the chronic pain market is projected to be propelled by the widespread existence of chronic pain patients, defined as individuals experiencing persistent or long-lasting pain that extends beyond the normal healing process or continues for over three months. This significant prevalence fuels the growth of the chronic pain market, as the increasing demand for effective pain management solutions, including pharmaceuticals and medical devices, generates opportunities for innovation and development within the industry. For instance, data from June 2024, provided by the Australian Institute of Health and Welfare, an Australia-based government agency, revealed that an estimated 4.0 million Australians (16% of the population) were affected by back problems in 2022. By 2023, back problems had become the third leading cause of disease burden, contributing 4.3% to the country’s total disease burden. Additionally, in February 2024, a report from the Institute for Health Metrics and Evaluation, a US-based national and international public health agency and research institute, projected global cases of neck pain to reach 269 million by 2050 (with a range of 219 to 322 million). Therefore, the prevalence of chronic pain patients is unequivocally driving the growth of the chronic pain market.

How Are Segments Identified Within The Chronic Pain Market Segment Framework?

The chronic pain market covered in this report is segmented –

1) By Product: Drug, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By End User: Hospitals, Clinics, Research Organization

Subsegments:

1) By Drug: Non-Opioid Analgesics, Opioids, Antidepressants, Anticonvulsants, Topical Analgesics, Corticosteroids

2) By Devices: Transcutaneous Electrical Nerve Stimulation (TENS) Units, Spinal Cord Stimulators, Intrathecal Drug Delivery Systems, Heat And Cold Therapy Devices, Bioelectronic Devices

What Trends Are Transforming The Chronic Pain Market?

Major companies within the chronic pain market are strategically forming partnerships to initiate shared savings programs for managing chronic pain. These strategic partnerships involve companies combining their strengths and resources to achieve mutual benefits and success. For instance, in August 2023, MOBE, a US-based digital health innovator company, teamed up with Override Health, a US-based healthcare company. Through this collaboration, they intend to address chronic pain management by implementing a shared savings program that integrates their specialized expertise. MOBE, as a health outcomes firm, employs health care data analytics to support its highly personalized, one-on-one health coaching and medication management approach. Conversely, Override offers a comprehensive program encompassing virtual interdisciplinary care, neuroplasticity-focused coaching, and peer support to assist individuals with chronic pain in navigating the challenges of disconnected care.

Who Are The Companies Competing Within The Chronic Pain Market?

Major companies operating in the chronic pain market are Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, Abbott Laboratories, Mitsubishi Chemical Group Corporation, GlaxoSmithKline plc., Eli Lilly and Company, AstraZeneca plc., Becton, Dickinson, and Company, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Biogen Inc., Endo International plc., Noven Pharmaceuticals Inc., Anika Therapeutics Inc., Collegium Pharmaceutical Inc., Heron Therapeutics Inc., Paradigm Biopharmaceuticals Ltd., Braeburn Inc., Taiwan Liposome Company Ltd., Axial Healthcare, AcelRx Pharmaceuticals Inc., Centrexion Therapeutics Corp., Vertanical GmbH, IKI Health Group, Tonix Pharmaceuticals Inc., Paperplane Therapeutics

Get The Full Chronic Pain Market Report:

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Which Region Is The Leading Market For The Chronic Pain Market?

North America was the largest region in the chronic pain market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Chronic Pain Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/chronic-pain-global-market-report

Browse Through More Reports Similar to the Global Chronic Pain Market 2026, By The Business Research Company

Pain Management Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/pain-management-drugs-global-market-report

Chronic Lower Back Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report

Neuropathic Pain Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuropathic-pain-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795